CCND1 and breast cancer: As a downstream target of microRNA-30a, EYA2 could boost the proliferation of breast cancer cells through driving G1/S cell cycle progression with up-regulation of cell cycle-related proteins cyclin A, cyclin D1, and cyclin E (43).